O	0	10	Comparison
O	11	13	of
O	14	17	the
O	18	26	efficacy
O	27	29	of
O	30	37	erector
O	38	44	spinae
O	45	50	plane
O	51	56	block
O	57	66	performed
O	67	71	with
O	72	81	different
O	82	96	concentrations
O	97	99	of
B-intervention	100	111	bupivacaine
O	112	114	on
B-condition	115	128	postoperative
I-condition	129	138	analgesia
O	139	144	after
O	145	155	mastectomy
O	156	163	surgery
O	163	164	:
O	165	175	ramdomized
O	175	176	,
O	177	188	prospective
O	188	189	,
O	190	196	double
O	197	204	blinded
O	205	210	trial
O	210	211	.

O	212	218	Breast
O	219	225	cancer
O	226	233	surgery
O	234	236	is
O	237	240	one
O	241	243	of
O	244	247	the
O	248	252	most
O	253	259	common
O	260	269	surgeries
O	270	275	among
O	276	279	the
O	280	286	female
O	287	297	population
O	297	298	.

O	299	305	Nearly
O	306	310	half
O	311	313	of
O	314	317	the
O	318	326	patients
O	327	333	suffer
O	334	341	chronic
O	342	346	pain
O	347	356	following
O	357	363	breast
O	364	370	cancer
O	371	378	surgery
O	378	379	,
O	380	383	and
O	384	386	24
O	386	387	%
O	388	390	of
O	391	395	them
O	396	408	categorizing
O	409	414	their
O	415	419	pain
O	420	422	as
O	423	431	moderate
O	432	434	to
O	435	439	high
O	439	440	.

O	441	443	In
O	444	448	this
O	449	454	study
O	454	455	,
O	456	463	effects
O	464	466	of
O	467	477	ultrasound
O	477	478	-
O	478	484	guided
O	485	492	erector
O	493	499	spinae
O	500	505	plane
O	506	507	(
O	507	510	ESP
O	510	511	)
O	512	517	block
O	518	527	performed
O	528	533	using
O	534	537	two
O	538	547	different
O	548	562	concentrations
O	563	565	of
O	566	577	bupivacaine
O	578	580	on
O	581	594	postoperative
O	595	603	tramadol
O	604	615	consumption
O	615	616	,
O	617	621	pain
O	622	628	scores
O	628	629	,
O	630	633	and
O	634	648	intraoperative
O	649	657	fentanyl
O	658	670	requirements
O	671	676	among
O	677	685	patients
O	686	689	who
O	690	699	underwent
O	700	707	radical
O	708	718	mastectomy
O	719	726	surgery
O	727	731	were
O	732	740	compared
O	740	741	.

O	742	746	This
O	747	753	double
O	753	754	-
O	754	761	blinded
O	761	762	,
O	763	774	prospective
O	774	775	,
O	776	779	and
O	780	790	randomized
O	791	796	study
O	797	805	included
O	806	814	patients
O	815	819	with
B-age	820	823	age
I-age	824	830	ranged
I-age	831	833	18
I-age	833	834	-
I-age	834	836	70
O	836	837	,
O	838	846	American
O	847	854	Society
O	855	857	of
O	858	874	Anesthesiologist
O	875	883	physical
O	884	890	status
O	891	892	I
O	892	893	-
O	893	895	II
O	895	896	,
O	897	900	and
O	901	910	scheduled
O	911	914	for
O	915	925	unilateral
O	926	934	modified
O	935	942	radical
O	943	953	mastectomy
O	954	961	surgery
O	961	962	.

O	963	966	The
O	967	975	patients
O	976	980	were
O	981	989	randomly
O	990	999	allocated
O	1000	1004	into
O	1005	1008	two
O	1009	1015	groups
O	1015	1016	.

O	1017	1019	In
O	1020	1025	group
O	1026	1027	I
O	1027	1028	,
O	1029	1032	ESP
O	1033	1038	block
O	1039	1042	was
O	1043	1052	performed
O	1053	1057	with
O	1058	1059	0
O	1059	1060	.
O	1060	1063	375
O	1063	1064	%
O	1065	1076	bupivacaine
O	1076	1077	.

O	1078	1080	In
O	1081	1086	group
O	1087	1089	II
O	1089	1090	,
O	1091	1094	ESP
O	1095	1100	block
O	1101	1104	was
O	1105	1114	performed
O	1115	1119	with
B-control	1120	1121	0
I-control	1121	1122	.
I-control	1122	1124	25
I-control	1124	1125	%
I-control	1126	1137	bupivacaine
O	1137	1138	.

O	1139	1146	General
O	1147	1157	anesthesia
O	1158	1161	was
O	1162	1169	induced
O	1170	1172	in
O	1173	1177	both
O	1178	1184	groups
O	1185	1194	according
O	1195	1197	to
O	1198	1201	the
O	1202	1210	standard
O	1211	1221	procedures
O	1221	1222	.

O	1223	1227	When
O	1228	1231	the
O	1232	1236	pain
O	1237	1242	score
O	1243	1246	was
O	1247	1248	≥
O	1248	1249	4
O	1249	1250	,
O	1251	1259	patients
O	1260	1268	received
O	1269	1280	intravenous
O	1281	1282	(
O	1282	1283	i
O	1283	1284	.
O	1284	1285	v
O	1285	1286	.
O	1286	1287	)
O	1288	1290	25
O	1291	1294	mcg
O	1295	1303	fentanyl
O	1304	1306	in
O	1307	1310	the
O	1311	1319	recovery
O	1320	1324	room
O	1325	1327	or
O	1328	1329	4
O	1330	1332	mg
O	1333	1335	of
O	1336	1344	morphine
O	1345	1347	in
O	1348	1351	the
O	1352	1360	surgical
O	1361	1365	ward
O	1366	1368	as
O	1369	1370	a
O	1371	1377	rescue
O	1378	1387	analgesia
O	1387	1388	.

O	1389	1392	The
O	1393	1397	main
O	1398	1410	measurements
O	1411	1415	were
O	1416	1429	postoperative
O	1430	1438	tramadol
O	1439	1450	consumption
O	1450	1451	;
O	1452	1461	Numerical
O	1462	1468	Rating
O	1469	1474	Scale
O	1475	1476	(
O	1476	1479	NRS
O	1479	1480	)
O	1481	1487	scores
O	1488	1490	15
O	1490	1491	,
O	1492	1494	30
O	1494	1495	,
O	1496	1499	and
O	1500	1502	60
O	1503	1506	min
O	1507	1510	and
O	1511	1513	12
O	1514	1517	and
O	1518	1520	24
O	1521	1522	h
O	1523	1538	postoperatively
O	1538	1539	;
O	1540	1543	and
O	1544	1558	intraoperative
O	1559	1567	fentanyl
O	1568	1580	requirements
O	1580	1581	.

O	1582	1584	In
O	1585	1590	total
O	1590	1591	,
B-total-participants	1592	1594	42
O	1595	1603	patients
O	1604	1605	(
B-intervention-participants	1605	1607	21
O	1608	1616	patients
O	1617	1619	in
O	1620	1624	each
O	1625	1630	group
O	1630	1631	)
O	1632	1636	were
O	1637	1645	included
O	1646	1648	in
O	1649	1652	the
O	1653	1658	study
O	1658	1659	.

O	1660	1663	The
B-outcome	1664	1668	mean
I-outcome	1669	1677	tramadol
I-outcome	1678	1689	consumption
O	1690	1692	at
O	1693	1696	the
O	1697	1710	postoperative
O	1711	1715	24th
O	1716	1717	h
O	1718	1721	was
B-iv-cont-mean	1722	1725	149
I-iv-cont-mean	1725	1726	.
I-iv-cont-mean	1726	1728	52
O	1729	1730	±
B-iv-cont-sd	1731	1733	25
I-iv-cont-sd	1733	1734	.
I-iv-cont-sd	1734	1736	39
I-iv-cont-sd	1737	1739	mg
O	1740	1742	in
O	1743	1748	group
O	1749	1750	I
O	1750	1751	,
O	1752	1755	and
B-cv-cont-mean	1756	1759	199
I-cv-cont-mean	1759	1760	.
I-cv-cont-mean	1760	1762	52
O	1763	1764	±
B-cv-cont-sd	1765	1767	32
I-cv-cont-sd	1767	1768	.
I-cv-cont-sd	1768	1770	78
I-cv-cont-sd	1771	1773	mg
O	1774	1776	in
O	1777	1782	group
O	1783	1785	II
O	1786	1787	(
O	1787	1788	p
O	1789	1790	=
O	1791	1792	0
O	1792	1793	.
O	1793	1796	001
O	1796	1797	)
O	1797	1798	.

O	1799	1801	In
O	1802	1807	group
O	1808	1809	I
O	1809	1810	,
O	1811	1814	the
B-outcome	1815	1818	NRS
I-outcome	1819	1825	scores
O	1826	1830	were
O	1831	1844	significantly
O	1845	1850	lower
O	1851	1853	at
O	1854	1859	every
O	1860	1864	time
O	1865	1871	points
O	1872	1880	compared
O	1881	1885	with
O	1886	1891	those
O	1892	1894	in
O	1895	1900	group
O	1901	1903	II
O	1903	1904	.

O	1905	1908	The
B-outcome	1909	1913	mean
I-outcome	1914	1928	intraoperative
I-outcome	1929	1937	fentanyl
I-outcome	1938	1949	requirement
O	1950	1953	was
O	1954	1961	similar
O	1962	1964	in
O	1965	1968	the
O	1969	1972	two
O	1973	1979	groups
O	1979	1980	.

O	1981	1989	Although
O	1990	1993	ESP
O	1994	1999	block
O	2000	2009	performed
O	2010	2014	with
O	2015	2019	both
O	2020	2034	concentrations
O	2035	2037	of
O	2038	2049	bupivacaine
O	2050	2058	provided
O	2059	2068	effective
O	2069	2082	postoperative
O	2083	2092	analgesia
O	2092	2093	,
O	2094	2097	the
O	2098	2104	higher
O	2105	2118	concentration
O	2119	2121	of
O	2122	2133	bupivacaine
O	2134	2147	significantly
O	2148	2155	reduced
O	2156	2169	postoperative
O	2170	2178	tramadol
O	2179	2190	consumption
O	2191	2196	after
O	2197	2204	radical
O	2205	2215	mastectomy
O	2216	2223	surgery
O	2223	2224	.

O	2225	2228	The
O	2229	2234	study
O	2235	2238	was
O	2239	2249	registered
O	2250	2263	prospectively
O	2264	2268	with
O	2269	2272	the
O	2273	2283	Australian
O	2284	2287	New
O	2288	2295	Zealand
O	2296	2304	Clinical
O	2305	2311	Trials
O	2312	2320	Registry
O	2321	2322	(
O	2322	2327	trial
O	2328	2330	ID
O	2330	2331	:
O	2332	2353	ACTRN12618001334291at
O	2354	2356	08
O	2356	2357	/
O	2357	2359	08
O	2359	2360	/
O	2360	2364	2018
O	2364	2365	)
O	2365	2366	.
